Publication: 3407

Publication: 3407

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 39 (25) 2803-2815

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 11

Parents:: 2601 2675 2901
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233331, UG1CA233337, UG1CA233373, UG1CA232760

Corr. Author:
Authors:: Karyn A. Goodman Fang-Shu Ou Nathan C. Hall Tanios Bekaii-Saab Briant Fruth Erin Twohy Michael O. Meyers Daniel J. Boffa Kisha Mitchell Wendy L. Frankel Donna Niedzwiecki Anne Noonan Yelena Y. Janjigian Paul J. Thurmes Alan P. Venook Jeffrey A. Meyerhardt Eileen M. O'Reilly David H. Ilson

Networks:: CA824, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, METROMIN, NY021

Study: CALGB-80803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: ORIGINAL REPORTS, Gastrointestinal Cancer